New cancer vaccine shows promising results for certain patients
There could be new hope on for kidney cancer patients. Researchers announced early results of an anti-tumor vaccine for ...
Medscape1mon
Metastatic Castration-resistant Prostate Cancer
Prespecified subset analyses suggest that ipilimumab may be most active ... Intravenous; mCRPC: Metastatic castration-resistant prostate cancer; P: Placebo; PSA: Prostate-specific antigen; q3w ...
Medscape5d
Recent Advances Revolutionize Treatment of Metastatic Prostate Cancer
Sipuleucel-T A therapeutic cancer ... melanoma (ipilimumab) are in Phase III testing in mCRPC and may provide additional immunotherapy options. Emerging Therapies in Prostate Cancer The ...
pharmaphorum4d
Merck drops last phase 3 Keytruda trial in prostate cancer
BMS has bucked the trend for late-stage immuno-oncology studies in prostate cancer in the CheckMate 650 trial Opdivo in combination with CTLA4 inhibitor Yervoy (ipilimumab), which showed modest ...
ascopubs.org8d
Combination Immunotherapy With Nivolumab Plus Ipilimumab in Melanoma of Unknown Primary
Erratum: Fulvestrant Versus Anastrozole in Endocrine Therapy–Naïve Women With Hormone Receptor–Positive Advanced Breast Cancer: Final Overall Survival in the Phase III FALCON Trial Supported in part ...